
- Volume 0 0
POOR QUALITY OF ANTICOAGULATION UPS RISK OF PTS
Approximately 30% of patients with an episode of adequately treated deep venousthrombosis (DVT) develop post-thrombotic syndrome (PTS) within 2 years. Studieshave shown that the average patient treated with warfarin spends only 60% of thetime in his or her goal international normalized ratio (INR) range of 2.0 to 3.0. A recentinvestigation of the relationship between subtherapeutic INRs and PTS demonstratedthat patients who spent more than 50% of their time below an INR of 2.0 had analmost 3-fold risk of developing PTS. Patients in this study were treated with warfarinfor at least 3 months and were followed for a maximum of 5 years to assess for signs,symptoms, and severity of PTS.
The authors concluded that low-quality treatment with warfarin is related to theoccurrence of PTS in patients with DVT. Strategies aimed at improving the qualityof long-term anticoagulation may have the potential to reduce the incidence of thiscomplication.
Dr. Garrett is a clinical pharmacist practitionerat Cornerstone Health Care in HighPoint, NC.
Articles in this issue
over 19 years ago
A Good Night's Rest—Helping the Patient with Insomniaover 19 years ago
Is Sleep-Driving for Real?over 19 years ago
Painful Diabetic Neuropathy: Alternative Treatmentsover 19 years ago
A New Day Dawns for NCPA and NACDSover 19 years ago
compounding HOTLINEover 19 years ago
RESPy AWARDover 19 years ago
ULM STUDENT NEEDED TO HELPover 19 years ago
Must an Embezzling Pharmacist Repay Wages Received?over 19 years ago
Web-based Program Aids Health Care Industryover 19 years ago
Depression: Identifying Symptoms and Appropriate TreatmentNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.